WF-2421

Overview

WF-2421 is an aldose reductase inhibitor with an IC 50 of 0.03 μM against rabbit-derived aldose reductase . WF-2421 acts as a non-competitive inhibitor of aldose reductase using dl-glyceraldehyde as the substrate. WF-2421 can be used in the research of diabetic complications (cataract, neuropathy, retinopathy, nephropathy).

Application

Products | Products > Disease Areas > Visual System Disease | Products > Disease Areas > Renal Disease | Products > Disease Areas > Type 1 Diabetes | Products > Disease Areas > Type 2 Diabetes | Products > Disease Areas > Neurological, Eye or Ear Disease | Products > Disease Areas > Inflammation or Immune System Disease | Products > Disease Areas > Metabolic or Endocrine Disease | Products > Disease Areas > Urogenital Disease | Products > Disease Areas > Autoimmune Disease | Products > Disease Areas > Glucose Metabolism | Products > Signaling Pathways > Metabolic Enzyme/Protease | Products > Research Areas > Neurological Disease | Products > Research Areas > Metabolic Disease | Products > Research Areas > Inflammation/Immunology | Products > Research Areas > Endocrinology | Products > Signaling Pathways > Aldose Reductase

Product Information

• Catalog No.: HY-183855
• CAS No.: 128429-19-6
• Molecular Formula: C19H20N2O8
• Molecular Weight: 404.37
• Storage: Please store the product under the recommended conditions in the Certificate of Analysis.

Source

Original product source